Martin J Duvall - Net Worth and Insider Trading
Martin J Duvall Net Worth
The estimated net worth of Martin J Duvall is at least $2 Million dollars as of 2024-04-19. Martin J Duvall is the EVP, CCO of ARIAD Pharmaceuticals Inc and owns about 93,039 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $2 Million. Martin J Duvall is also the CEO of Tocagen Inc and owns about 907 shares of Tocagen Inc (TOCA) stock worth over $17,142. Details can be seen in Martin J Duvall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Martin J Duvall has not made any transactions after 2019-05-28 and currently still holds the listed stock(s).
Transaction Summary of Martin J Duvall
Martin J Duvall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin J Duvall owns 2 companies in total, including Forte Biosciences Inc (FBRX) , and ARIAD Pharmaceuticals Inc (ARIA) .
Click here to see the complete history of Martin J Duvall’s form 4 insider trades.
Insider Ownership Summary of Martin J Duvall
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FBRX | Forte Biosciences Inc | 2017-04-12 | director & Chief Executive Officer |
| ARIA | ARIAD Pharmaceuticals Inc | 2016-04-29 | EVP & CCO |
Martin J Duvall Latest Holdings Summary
Martin J Duvall currently owns a total of 2 stocks. Among these stocks, Martin J Duvall owns 93,039 shares of ARIAD Pharmaceuticals Inc (ARIA) as of March 19, 2016, with a value of $2 Million and a weighting of 99.24%. Martin J Duvall also owns 907 shares of Tocagen Inc (TOCA) as of May 28, 2019, with a value of $17,142 and a weighting of 0.76%.
Latest Holdings of Martin J Duvall
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2016-03-19 | 93,039 | 23.99 | 2,232,006 |
| TOCA | Tocagen Inc | 2019-05-28 | 907 | 18.90 | 17,142 |
Holding Weightings of Martin J Duvall
Martin J Duvall Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin J Duvall has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 4,000 shares on March 19, 2016, which brought Martin J Duvall around $25,880.
According to the SEC Form 4 filings, Martin J Duvall has made a total of 1 transactions in Tocagen Inc (TOCA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tocagen Inc is the acquisition of 333 shares on May 28, 2019, which cost Martin J Duvall around $21,700.
Insider Trading History of Martin J Duvall
- 1
Martin J Duvall Trading Performance
GuruFocus tracks the stock performance after each of Martin J Duvall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin J Duvall is -14.94%. GuruFocus also compares Martin J Duvall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin J Duvall within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martin J Duvall's insider trading performs compared to the benchmark.
Performance of Martin J Duvall
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 54.63 | -14.94 | -85 | -69.58 | ||
| Relative Return to S&P 500(%) | 49.66 | -17.99 | -97.53 | -77.67 |
Martin J Duvall Ownership Network
Ownership Network List of Martin J Duvall
Ownership Network Relation of Martin J Duvall
Martin J Duvall Owned Company Details
What does Forte Biosciences Inc do?
Who are the key executives at Forte Biosciences Inc?
Martin J Duvall is the director & Chief Executive Officer of Forte Biosciences Inc. Other key executives at Forte Biosciences Inc include director & See Remarks Paul A. Wagner , See remarks Hubert C Chen , and Chief Financial Officer Antony A Riley .
Forte Biosciences Inc (FBRX) Insider Trades Summary
Over the past 18 months, Martin J Duvall made no insider transaction in Forte Biosciences Inc (FBRX). Other recent insider transactions involving Forte Biosciences Inc (FBRX) include a net purchase of 218,865 shares made by Paul A. Wagner ,
In summary, during the past 3 months, insiders sold 0 shares of Forte Biosciences Inc (FBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forte Biosciences Inc (FBRX) were sold and 218,865 shares were bought by its insiders, resulting in a net purchase of 218,865 shares.
Forte Biosciences Inc (FBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Forte Biosciences Inc Insider Transactions
Martin J Duvall Mailing Address
Above is the net worth, insider trading, and ownership report for Martin J Duvall. You might contact Martin J Duvall via mailing address: Mgi Pharma, Inc., 5775 West Old Shakopee Road, Suite 100, Bloomington Mn 55437.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
